Through the GSK-3β-EZH2-STAT3 axis, it is involved in the self-renewal of Glioblastoma Stem Cells (GSCs) and the development of resistance to TMZ (a chemotherapy drug) in GBM. This evidence concerns the gene GSK3B and glioblastoma.